Personalized health check-up support for 11 islanders...Digital healthcare will help eliminate medical blind spots
Jun 18, 2025
|
The examination, which was conducted as part of the Community-linked Medical Welfare Social Contribution Project at Korea University Ansan Hospital, was tailored one-on-one for a total of 11 residents on the island island, located about an hour and a half by boat from the ballistic port of Ansan, Gyeonggi-do. Basic health checkups and professional health counseling were included. Based on the results of the test conducted directly at the site, the health status of each resident was systematically checked and the direction of future necessary management was suggested, laying the foundation for sustainable health management beyond single-shot treatment.
In particular, Daewoong Pharmaceutical's digital healthcare technology was actively utilized in this activity. ▲Wearable ECG Devices"MobiCARE"▲Ring Continuous Blood Pressure Measurement Device"CART BP Pro"▲Continuous Blood Pressure Measurement Device"FreeStyle Libre"▲AI-based Blind Disease Diagnosis Assistance Solution"WISKY"▲By utilizing the fundus camera"Optina Genesis" and others, advanced screening services that are difficult to access in the existing medical environment were provided. Through this, elderly residents were able to check their health conditions more easily and accurately.
In fact, 4 out of 10 people who confirmed their fundus condition using Optina and whiskey were found to have abnormalities, and two of them were recommended for a detailed ophthalmological examination because they were suspected of glaucoma, one for macular degeneration, and one for diabetic retinopathy. Even though it is a small-scale screening for a short period of time, the confirmation of suspected cases of actual diseases is a result of the effectiveness of digital healthcare devices, especially early detection of blindness with few symptoms of self-awareness.
Starting with this activity, Daewoong Pharmaceutical plans to expand medical support to various classes in medical blind spots such as foreign workers and multicultural families in Ansan, and build a global win-win medical model through telemedicine cooperation between Gyeonggi-do and Sri Lanka in the long run.
Cho Byung-ha, head of Daewoong Pharmaceutical's digital healthcare business division, said "This island area screening support was a small but meaningful step toward narrowing the medical gap between regions."We will continue to carry out medical support activities so that various members of society can enjoy healthy lives in the future." he said.
This article was translated by Naver AI translator.
